affective disorder/depression Flashcards

1
Q

what is the monoamine hypothesis of depression and what is it based on

A

monoamine hypothesis: suggests depression is caused by functional defecit of noradrenaline, 5-HT and possibly dopamine in brain

therapeutic effects of antidepressant drugs attributed to augmentation or prolongation of actions of monoaminergic transmission in brain

based on:

reserpine; monoamine depletory used to treat schizo and hypertension, causes severe depression in 15% of patients

iproniazid; MAO-inhibitor, used to treat tuberculosis, sometimes induces euphoria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how is monoamine transmission modulated in antidepressant treatment

A

either;

increasing amount of transmitter released from nerve terminal (MAO inhibitors or mianserin)

preventing reuptake of released transmitter from synapse( tricyclics and selective uptake blockers)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is mechanism for MAOs in depression

A

NA metabolised within nerve after reuptake from synapse by MAO; inhibition of the intraneuronal enzyme MAO leads to accumulation of monoamines primarily NA and 5HT

MAO inhibitors increase amount of treatment available for release, thereby increasing monoamine transmission

2 MAO isoenzymes; MAO-A and MAO-B

5HT and NA mainly; metabolised by MAO-A

dopamine metabolised by MAO-B (dopamine (and tyramine) non selective for MAO isotypes however are usually still metabolised by MAO B)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how are MAO inhibitors used to treat depression

A

MAO inhibitors: phenelzine and maclobemide

maclobemide is MAO-A inhibitor

phenelzine is non selective MAO inhibitor

MAO-B inhibitors have little treatment in depression, are used as adjunct in parkinsons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are negative side ffects of MAO inhibitors

A

hepatotoxicity (rare but can be severe)

CNS side effects such as insomnia and agitation

postural hypotension due to potentiating effects of dopamine at autonomic ganglia (reduction in NA effects)

sympathetic effects; dry mouth, sweating, lack of appetitep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what type of uptake inhibitors are used in treatment of depression

A

uptake inhibitors include tricyclics and 2nd generation antidepressants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how are tricyclic antidepressants used

A

they block reuptake of monoamines

these compounds are related to phenothiazines and share many of their side effects such as dry mouth

in vitro tricyclics block neuronal uptake of both noradrenaline and 5HT

in vivo the metabolites of most of these compounds only inhibit uptake of NA

only clomipramine has selectivity against 5HT uptake in vivo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are adverse effects of tricyclics

A

most negative effects due to antagonism of alpha 1 receptors, muscarinic and H1 receptors

adverse effects:

antimuscarinic activity: sedation, dry mouth, blurred vision

postural hypotension due to central action

cardiac dysrhythmias including ventricular fibrillation

convulsions mimicking epilepsy

confusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how are selective uptake blockers used to treat depression

A

they are 2nd gen antidepressants:

developed to produce fewer side effects than tricyclics especially antimuscarinic and cardiotoxic effects

2nd gen antidepressants include:

selective NA reuptake blockers such as maprotilline

selective 5HT reuptake inhibitors (SSRIs) such as fluoxetine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how are SNRIs used in depression

A

serotonin noradrenaline reuptake inhibitors

most recent agents to be developed

non selective inhibitors of noradrenaline and 5HT reuptake

they have no significant antimuscarinic activity

inhibition of 5HT is maintained in vivo unlike most tricyclics

e.g venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how are atypical antidepressants used

A

e.g iprindole and mianserin

neither drugs has any effect on monoamine reuptake

mechanisms underlying therapeutic effects of iprindole are unknown

mianserin is an alpha 2 adrenoceptor antagonist, preventing negative feedback inhibition of noradrenaline release, by presynaptic terminal alpha 2 autoreceptors

mianserin an antagonist for 5HT receptors (1d, 2a and 2c subtypes), which can explain its therapeutic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are adverse effects of atypical antidepressants

A

negative side effects resemble tricyclics, particular problems include:

epileptogenesis

extrapyramidal and skin reactions

hepato and renal toxicity (especially mianserin)

postural hypotension (especially mianserin)

blood dyscrasias (especially mianserin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are other antidepressant used (other than MAO inhibitors, 2nd gen and atypical antidepressants)

A

benzos: e.g alprazolam and adinazolam

normally used to treat anxiety and are normally ineffective in depression, however triazolo and pyrazolo derivatives have both anxiolytic and antidepressant actions

main adverse effect is sedation

mirtazepine: a NA reuptake inhibitor and alpha 2 antagonist also used to treat depression
trazodone: 5HT reuptake inhibitor, 5HT2 receptor antagonist

^these 2 combine monoamine receptor uptake inhibition with receptor actions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are problems with monoamine hypothesis of depression

A

iprindole used to treat depression, no known effects on monoamine turnover

pharmacological actions of antidepressants are apparent shortly after administration, however clinically there is a therapeutic lag of 2-3 weeks

many uptake blockers are not antidepressants e.g cocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the cheese reaction

A

tyramine normally metabolised by MAO in the gut

when MAO is inhibited tyramine diffuses into circulation and is taken up by sympathetic neurones

tyramine is an indirect sympathomimetic (see adrenergic notes), acts as “false transmitter”

release of noradrenaline into synapse is independent of neuronal activity and culiminates in exaggerated sympathetic drive

because of this potentially dangerous side effect early MAO inhibitors were reserved mainly for treatment of agititated depression (depression w anxiety) but a tyramine free diet was mandatory

tyramine is found in cheese, red wine and marmite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are biochemical changes that occur after chronic administration of antidepressant treatments

A

long latency, long lasting changes may occur such as changes in density and/or affinity of neurotransmitter receptors

receptors that show adaptive changes include; adrenoceptors, 5HT 1a and 2 subtypes, GABAb receptors

changes depend on particular drug and brain region

17
Q

what is mania and how is it treated

A

mania and bipolar disorder (manic depression) are most effectively treated with neuroleptic agents or lithium

18
Q

how is lithium used

A

only used in treatment of manic depression and mania

therapeutic effects are unexplained but it has many actions effectin neuronal function

it accumulates intraneuronally, causing partial depolarisation and attenuation of transmitter release

disrupts cAMP synthesis and phosphatidyl inositol (PI) metabolism

PI is a IP3 precursor preventing regeneration of PI and possibly IP3 formation

ineffective in treatment of unipolar depression

reduces number of adrenoceptors in brain

19
Q

what are adverse effects of lithium

A

nephrotoxicity
hypothyroidism
CNS effects which can culminate in coma and death

high plasma levels of drug required (1mM), it is toxic and small therapeutic index

20
Q

how is ketamine used, what is its mechanism

A

is a dissociatve anaesthetic

has acute and rapid (no therapeutic lag) effect in trials with depression

NMDA receptor antagonist
enchance AMP receptor activation

disinhibits glutamate release by inhibition of GABA neurones

upregulates BDNF pathway